(106-16) A Pilot Multi-Arm Study of sEphB4-HSA In Combination with Different Chemotherapy Regimens in Patients with Specific Advanced or Metastatic Solid Tumors (Phase 1 clinical trial, appropriate for patients with metastatic cancers of the bile duct, gallbladder; head and neck; non-small cell lung; and pancreas.)
(134-17) A Phase IIa trial of sEphB4-HSA in combination with Anti PD-1 Antibody (Pembrolizumab, MK-3475) in patients with non-small cell lung and head/neck cancer (Phase 2 clinical trial, appropriate for patients with lung, head or neck cancer.)
(194-17) A Phase 1/2a Study of BMS-986242 Administered in Combination with Nivolumab (BMS--936558, Anti-PD-1) in Advanced Malignant Tumors (Phase 1/2 clinical trial, appropriate for patients with advanced malignant tumors.)